Compound ID | 3556

Update compound information

TB47

Class: QcrB inhibitor

Details of activity: Active against Mycobacterium tuberculosis including multidrug-resistant strains; cytochrome bcc complex inhibitor (cytochrome b subunit of complex III inhibitor [QcrB inhibitor])
Description: Synthetic compound; high selectivity index against THP-1, VERO, and HepG2 cell lines; high oral bioavailability in rats; shows synergistic effects with rifampicin and pyrazinamide
Year first mentioned: 2015
Highest developmental phase: Preclinical
Development status: Experimental
Chemical structure(s):
Click here for structure editor
Molecular weight: 538.56
Iso. SMILES: CC1=NN2C=CC(=CC2=C1C(=O)NCC3=CC=C(C=C3)N4CCC(CC4)C5=CC=C(C=C5)OC(F)(F)F)OC
InChI Key: HQECXZKIRDUGLC-UHFFFAOYSA-N
Can. SMILES: CC1=NN2C=CC(=CC2=C1C(=O)NCC3=CC=C(C=C3)N4CCC(CC4)C5=CC=C(C=C5)OC(F)(F)F)OC
InChI: InChI=1S/C29H29F3N4O3/c1-19-27(26-17-25(38-2)13-16-36(26)34-19)28(37)33-18-20-3-7-23(8-4-20)35-14-11-22(12-15-35)21-5-9-24(10-6-21)39-29(30,31)32/h3-10,13,16-17,22H,11-12,14-15,18H2,1-2H3,(H,33,37)
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/122188597
Citation: https://journals.asm.org/doi/10.1128/aac.00706-21?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.